• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pharmaids Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3844.0
  • ISIN : INE117D01018
60.97 -2 (-2.91%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    60.11

  • Today’s High

    63.00

  • Open

    60.11

  • Perv Close

    62.80

  • 52W Low

    31.90

  • 52W High

    87.46

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    221.48

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.09

  • Debt-Equity Ratio

    -2.91

  • AGM Date

    03-Sep-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    221.48

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    35.27

  • BV (₹)

    18.10

  • Sales( ₹ in Cr.)

    2.34

  • NP (in Cr.)

    -7.28

  • NP Var(%)

    -47.0

  • Div%

    0.0

  • CPS (₹)

    -2.00

  • EPS (₹)

    -2.10

  • Traded Value (₹ in Lakhs)

    221.48

  • 52 Week High

    87.46

  • 52 Week Low

    31.90

  • Price BSE

    63.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    221.48

  • P/C Ratio

    -31.40

  • P/E Ratio

    -30.50

  • Price Vs.BV

    -2.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 2.34 0.03 0.00 3.94 8.55 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2.34 0.03 0.00 3.94 8.55 0.00
Other Income 1.02 0.80 0.00 0.02 0.03 0.00
Stock Adjustments 9.54 0.23 -0.89 0.52 0.37 0.00
Total Income 12.90 1.06 -0.89 4.48 8.95 0.00
EXPENDITURE :            
Raw Materials 11.55 0.25 0.00 4.09 8.53 0.00
Power and Fuel Cost 0.05 0.01 0.00 0.00 0.00 0.00
Employee Cost 3.42 1.99 1.13 0.04 0.04 0.02
Other Manufacturing Expenses 0.02 0.04 0.02 0.00 0.00 0.01
Selling and Administration Expenses 1.68 1.45 0.80 0.19 0.23 0.23
Miscellaneous Expenses 2.42 2.88 7.06 0.00 0.01 0.07
Employee Benefit Expenses 3.42 1.99 1.13 0.04 0.04 0.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 19.14 6.62 9.00 4.32 8.82 0.34
Operating Profit -6.24 -5.58 -9.89 0.15 0.13 -0.34
Interest 2.15 0.33 0.00 0.00 0.00 0.00
Gross Profit -8.39 -5.91 -9.89 0.15 0.13 -0.34
Depreciation 0.20 0.18 0.02 0.01 0.04 0.04
Profit Before Tax -8.59 -6.09 -9.91 0.14 0.09 -0.38
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.31 -1.14 -2.35 0.00 0.00 -0.41
Reported Net Profit -7.28 -4.95 -7.56 0.15 0.09 0.03
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -7.28 -4.95 -7.56 0.15 0.09 0.03
Adjustment below Net Profit 0.00 -0.04 0.00 0.00 0.00 0.00
P & L Balance brought forward -14.88 -9.89 -2.33 -2.48 -2.57 -2.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -22.16 -14.88 -9.89 -2.33 -2.48 -2.57
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.06 -1.40 -3.52 0.14 0.09 0.03
Earnings Per Share(Adj)-Unit Curr -2.06 -1.40 -3.52 0.14 0.09 0.03
Book Value 18.09 20.15 10.46 8.44 8.30 8.21
Book Value(Adj)-Unit Curr 18.09 20.15 10.46 8.44 8.30 8.21

Shareholding Pattern

  • Promoter Group

    5.14%

  • Public Share Holding

    94.86%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,813,174 5.14 1,813,174 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,813,174 5.14 1,813,174 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,679,392 4.76 1,678,392 18
Clearing Members 0 0.00 0 0
Directors of their Relatives 14,398,756 40.83 14,398,756 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 499,395 1.42 499,395 39
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 6,621 0.02 6,621 4
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,480,343 26.88 9,388,413 63
Individuals holding nominal share capital up to Rs. 1 lakh 3,338,721 9.47 2,450,520 7,818
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,130,612 3.21 1,130,612 3
Sub Total 33,454,638 94.86 32,473,507 8,013
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 35,267,812 100.00 34,286,681 8,026

Company Background

Pharmaids Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Pharmaids Pharmaceuticals Ltd
  • BSE Code : 3844.0
  • ISIN : INE117D01018

  • Incorporation Year

    1989

  • Registered Office

    4-4-211/212/3 1st Floor
    Inderbagh Sulthan Bazar, Hyderabad,
    Telangana-500095

  • Telephone

    91-40-66669809

  • FAX

    91-40-23232348

  • Chairman

    Shankarappa Nagaraja Vinaya Babu

  • Managing Director

  • Company Secretary

    Prasanna Subramanya Bhat.

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Pharmaids Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pharmaids Pharma 62.80 3.36 2.34 -22.11 0.00
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10